| Name
|
Tamra-BNP (1-32), human
|
| Code
|
[114471-18-0]
|
| The alias
|
Tamra-BNP (1-32), human
|
| Sequence (single letter abbreviation)
|
TAMRA-SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Cys10 and 26 bridge)
|
| Sequence (three-letter abbreviation)
|
Tamra-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH (trifluoroacetate salt)(Cys10 and 26 bridge)
|
| A basic description
|
|
| solubility
|
|
| The molecular weight
|
3878.6
|
| Chemical formula
|
C168H266N52O46S4
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
T. Sudoh et al., BBRC, 159, 1427 (1989)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys10 and 26 bridge)
|